RAPT
RAPT Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$58.01
+0.00%Leverage
- Debt / equity
- 0.02x
- Net debt / equity
- -0.23x
- Debt / assets
- 0.02x
- Debt / EBITDA
- -0.02x
- Net debt / EBITDA
- 0.33x
Liquidity & coverage
- Current ratio
- 12.04x
- Quick ratio
- 12.04x
- Cash ratio
- 11.76x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- $147.7M
Cash & dividend
- FCF / debt
- -33.38x
- Cash flow / debt
- -33.35x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Sep 1, 2025